» Articles » PMID: 38060041

Review of the Potential Pharmacological Role of Erucic Acid: a Monounsaturated Omega-9 Fatty Acid

Overview
Specialty Pharmacology
Date 2023 Dec 7
PMID 38060041
Authors
Affiliations
Soon will be listed here.
Abstract

This comprehensive review aims to provide an overview of the pharmacological properties of erucic acid (EA) and highlight areas that require further research. EA is an omega-9 fatty acid found in certain vegetable oil, such as rapeseed oil has demonstrated favourable effects in rodents, including ameliorating myocardial lipidosis (fat accumulation in the heart muscle), congestive heart disease, hepatic steatosis (fat accumulation in the liver), and memory impairments. These findings have prompted regulatory bodies to establish limits on EA content in food oils. The studies were performed on rodents and led to caution on ingesting the EA at high levels. Moreover, EA is frequently utilized as a nutritional supplement for the treatment of adrenoleukodystrophy, myocardial disease, and memory improvement. The review of the article indicated that EA improves cognitive function, has a part in Huntington's disease, interacts with peroxisome proliferator-activated receptors, inhibits elastase and thrombin, has anti-inflammatory, antioxidant, and anti-tumour properties, and inhibits influenza A virus. This article elucidates the pharmacological effects of EA, an omega-9 fatty acid.

Citing Articles

Effect of PM exposure on susceptibility to allergic asthma in elderly rats treated with allergens.

Zhao L, Ding X, Zhou L, Song C, Kang T, Xu Y Sci Rep. 2025; 15(1):5594.

PMID: 39955443 PMC: 11830082. DOI: 10.1038/s41598-025-90261-3.


The Relationship Between Body Composition Parameters and the Intake of Selected Nutrients, and Serum Anti-Müllerian Hormone (AMH) Levels in the Context of Ovulatory Infertility.

Skowronska M, Pawlowski M, Buczynska A, Wiatr A, Dyszkiewicz A, Wenta A Nutrients. 2024; 16(23).

PMID: 39683543 PMC: 11644442. DOI: 10.3390/nu16234149.

References
1.
Altinoz M, Ozpinar A . PPAR-δ and erucic acid in multiple sclerosis and Alzheimer's Disease. Likely benefits in terms of immunity and metabolism. Int Immunopharmacol. 2019; 69:245-256. DOI: 10.1016/j.intimp.2019.01.057. View

2.
Altinoz M, Bilir A, Elmaci I . Erucic acid, a component of Lorenzo's oil and PPAR-δ ligand modifies C6 glioma growth and toxicity of doxorubicin. Experimental data and a comprehensive literature analysis. Chem Biol Interact. 2018; 294:107-117. DOI: 10.1016/j.cbi.2018.08.024. View

3.
Altinoz M, Ozpinar A, Ozpinar A, Hacker E . Erucic acid, a nutritional PPARδ-ligand may influence Huntington's disease pathogenesis. Metab Brain Dis. 2019; 35(1):1-9. DOI: 10.1007/s11011-019-00500-6. View

4.
Altinoz M, Elmaci I, Hacimuftuoglu A, Ozpinar A, Hacker E, Ozpinar A . PPARδ and its ligand erucic acid may act anti-tumoral, neuroprotective, and myelin protective in neuroblastoma, glioblastoma, and Parkinson's disease. Mol Aspects Med. 2020; 78:100871. DOI: 10.1016/j.mam.2020.100871. View

5.
Arai T, Miklossy J, Klegeris A, Guo J, McGeer P . Thrombin and prothrombin are expressed by neurons and glial cells and accumulate in neurofibrillary tangles in Alzheimer disease brain. J Neuropathol Exp Neurol. 2006; 65(1):19-25. DOI: 10.1097/01.jnen.0000196133.74087.cb. View